Exclusive

Publication

Byline

Location

US Patent Issued to KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY on Aug. 18 for "RNA expression modulating or editing method via regulation of Cas13 protein" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,742, issued on Aug. 18, was assigned to KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, South Korea). "RNA expression modulati... Read More


US Patent Issued to CHINA AGRICULTURAL UNIVERSITY on Aug. 18 for "Compositions and methods for CRISPR/Cas-based gene editing" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,743, issued on Aug. 18, was assigned to CHINA AGRICULTURAL UNIVERSITY (Beijing). "Compositions and methods for CRISPR/Cas-based gene editin... Read More


US Patent Issued to Novozymes on Aug. 18 for "Xylanase variants and polynucleotides encoding same" (Danish Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,744, issued on Aug. 18, was assigned to Novozymes A/S (Bagsvaerd, Denmark). "Xylanase variants and polynucleotides encoding same" was inven... Read More


US Patent Issued to Brandeis University on Aug. 18 for "Tethering cysteine residues using cyclic disulfides" (Rhode Island, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,745, issued on Aug. 18, was assigned to Brandeis University (Waltham, Mass.). "Tethering cysteine residues using cyclic disulfides" was inv... Read More


US Patent Issued to The Board of Regents of The University of Texas System on Aug. 18 for "Cancer treatment through RLIP76 partial depletion" (Texas Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,746, issued on Aug. 18, was assigned to The Board of Regents of The University of Texas System. "Cancer treatment through RLIP76 partial de... Read More


US Patent Issued to BATTELLE MEMORIAL INSTITUTE on Aug. 18 for "Rapid design, build, test, and learn technologies for identifying and using non-viral carriers" (Ohio, California Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,747, issued on Aug. 18, was assigned to BATTELLE MEMORIAL INSTITUTE (Columbus, Ohio). "Rapid design, build, test, and learn technologies fo... Read More


US Patent Issued to Alnylam Pharmaceuticals on Aug. 18 for "Huntingtin (HTT) iRNA agent compositions and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,748, issued on Aug. 18, was assigned to Alnylam Pharmaceuticals Inc. (Cambridge, Mass.). "Huntingtin (HTT) iRNA agent compositions and meth... Read More


US Patent Issued to The University of Western Australia on Aug. 18 for "Antisense molecules and methods for treating pathologies" (Australian Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,749, issued on Aug. 18, was assigned to The University of Western Australia (Crawley, Australia). "Antisense molecules and methods for trea... Read More


US Patent Issued to TANABE PHARMA on Aug. 18 for "Agent for preventing or treating muscular disease" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,750, issued on Aug. 18, was assigned to TANABE PHARMA Corp. (Osaka, Japan). "Agent for preventing or treating muscular disease" was invente... Read More


US Patent Issued to Alnylam Pharmaceuticals on Aug. 18 for "Mannan binding lectin serine peptidase 2 (MASP2) IRNA compositions and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,751, issued on Aug. 18, was assigned to Alnylam Pharmaceuticals Inc. (Cambridge, Mass.). "Mannan binding lectin serine peptidase 2 (MASP2) ... Read More